Cargando…

Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma

Detalles Bibliográficos
Autores principales: Liu, Shanshan, Zhou, Hongwei, Xu, Weiling, Jin, Tao, Liang, Xinyue, Zhao, Xiaoxia, Dai, Yun, Jin, Fengyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907188/
https://www.ncbi.nlm.nih.gov/pubmed/36752844
http://dx.doi.org/10.1007/s00277-023-05120-w
_version_ 1784884124129951744
author Liu, Shanshan
Zhou, Hongwei
Xu, Weiling
Jin, Tao
Liang, Xinyue
Zhao, Xiaoxia
Dai, Yun
Jin, Fengyan
author_facet Liu, Shanshan
Zhou, Hongwei
Xu, Weiling
Jin, Tao
Liang, Xinyue
Zhao, Xiaoxia
Dai, Yun
Jin, Fengyan
author_sort Liu, Shanshan
collection PubMed
description
format Online
Article
Text
id pubmed-9907188
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99071882023-02-09 Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma Liu, Shanshan Zhou, Hongwei Xu, Weiling Jin, Tao Liang, Xinyue Zhao, Xiaoxia Dai, Yun Jin, Fengyan Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2023-02-08 2023 /pmc/articles/PMC9907188/ /pubmed/36752844 http://dx.doi.org/10.1007/s00277-023-05120-w Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Liu, Shanshan
Zhou, Hongwei
Xu, Weiling
Jin, Tao
Liang, Xinyue
Zhao, Xiaoxia
Dai, Yun
Jin, Fengyan
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
title Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
title_full Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
title_fullStr Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
title_full_unstemmed Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
title_short Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
title_sort early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907188/
https://www.ncbi.nlm.nih.gov/pubmed/36752844
http://dx.doi.org/10.1007/s00277-023-05120-w
work_keys_str_mv AT liushanshan earlyleukoencephalopathyduringdaratumumabtreatmentinapatientwithmultiplemyeloma
AT zhouhongwei earlyleukoencephalopathyduringdaratumumabtreatmentinapatientwithmultiplemyeloma
AT xuweiling earlyleukoencephalopathyduringdaratumumabtreatmentinapatientwithmultiplemyeloma
AT jintao earlyleukoencephalopathyduringdaratumumabtreatmentinapatientwithmultiplemyeloma
AT liangxinyue earlyleukoencephalopathyduringdaratumumabtreatmentinapatientwithmultiplemyeloma
AT zhaoxiaoxia earlyleukoencephalopathyduringdaratumumabtreatmentinapatientwithmultiplemyeloma
AT daiyun earlyleukoencephalopathyduringdaratumumabtreatmentinapatientwithmultiplemyeloma
AT jinfengyan earlyleukoencephalopathyduringdaratumumabtreatmentinapatientwithmultiplemyeloma